Flucovag: efficacy and safety in patients with vulvovaginal candidiasis: a prospective, multicenter, open-label, randomized, comparative clinical study

Flucovag: efficacy and safety in patients with vulvovaginal candidiasis: a prospective, multicenter, open-label, randomized, comparative clinical study

Design. A prospective, multicenter, open-label, randomized, comparative clinical study. Objective. To compare the efficacy and safety of Flucovag (sertaconazole) vaginal suppositories, 300 mg (OTCPharm JSC, Russia; manufactured by Altpharm LLC, Russia) and the brand-name drug Zalain (sertaconazol...

Full description

Bibliographic Details
Main Authors: Flora R. Kutueva, Ruslan I. Glushakov, Natalia I. Tapilskaya, Alla E. Nikolaeva, Artem A. Poromov, Olga A. Pustotina
Format: Article
Language:Russian
Published: IP Berlin A.V. 2023-04-01
Series:Гинекология
Subjects:
vulvovaginal candidiasis
vaginitis
c. albicans
non-albicans candida
fungicidal
fungistatic effect
Online Access:https://gynecology.orscience.ru/2079-5831/article/viewFile/106893/pdf

Internet

https://gynecology.orscience.ru/2079-5831/article/viewFile/106893/pdf

Similar Items